Gold nanoparticles enhance anti-tumor effect of radiotherapy to hypoxic tumor

Radiation Oncology Journal

Volumn 34, Issue 3, 2016, Pages 230-238

  Kim, Mi Sun ^a,c   Lee, Eun Jung ^a   Kim, Jae Won ^a   Chung, Ui Seok ^b   Koh, Won Gun ^b   Keum, Ki Chang ^a   Koom, Woong Sub ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c CHA University   (South Korea)

Author keywords

Hypoxia; Nanoparticle; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; GOLD NANOPARTICLE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS ASSAY; ARTICLE; CANCER INHIBITION; CHEMORADIOTHERAPY; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; CYTOTOXICITY; HYPOXIA; IMMUNOFLUORESCENCE TEST; MOUSE; MTT ASSAY; NEOPLASM; NONHUMAN; RADIATION DOSE; RADIOSENSITIVITY; TUMOR HYPOXIA; TUMOR VOLUME; TUMOR XENOGRAFT; TUNEL ASSAY;

EID: 84990996804     PISSN: 22341900     EISSN: 22343164     Source Type: Journal    
DOI: 10.3857/roj.2016.01788     Document Type: Article

References (26)

1. Harris AL. Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2: 38-47.
2. Overgaard J. Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Radiother Oncol 2011;100: 22-32.
3. Harada H. How can we overcome tumor hypoxia in radiation therapy? J Radiat Res 2011;52: 545-56.
4. Barker HE, Paget JT, Khan AA, Harrington KJ. The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 2015;15: 409-25.
5. Semenza GL. Intratumoral hypoxia, radiation resistance, and HIF-1. Cancer Cell 2004;5: 405-6.
6. Han G, Ghosh P, Rotello VM. Functionalized gold nanoparticles for drug delivery. Nanomedicine (Lond) 2007;2: 113-23.
7. Zhao Y, Yu B, Hu H, Hu Y, Zhao NN, Xu FJ. New low molecular weight polycation-based nanoparticles for effective codelivery of pDNA and drug. ACS Appl Mater Interfaces 2014;6: 17911-9.
8. Qian X, Peng XH, Ansari DO, et al. In vivo tumor targeting and spectroscopic detection with surface-enhanced Raman nanoparticle tags. Nat Biotechnol 2008;26: 83-90.
9. Perrault SD, Walkey C, Jennings T, Fischer HC, Chan WC. Mediating tumor targeting efficiency of nanoparticles through design. Nano Lett 2009;9: 1909-15.
10. Conde J, Rosa J, de la Fuente JM, Baptista PV. Gold-nanobeacons for simultaneous gene specific silencing and intracellular tracking of the silencing events. Biomaterials 2013;34: 2516-23.
11. Hainfeld JF, Slatkin DN, Smilowitz HM. The use of gold nanoparticles to enhance radiotherapy in mice. Phys Med Biol 2004;49: N309-15.
12. Roeske JC, Nunez L, Hoggarth M, Labay E, Weichselbaum RR. Characterization of the theorectical radiation dose enhancement from nanoparticles. Technol Cancer Res Treat 2007;6: 395-401.
13. Cho SH, Jones BL, Krishnan S. The dosimetric feasibility of gold nanoparticle-aided radiation therapy (GNRT) via brachytherapy using low-energy gamma-/x-ray sources. Phys Med Biol 2009;54: 4889-905.
14. Rahman WN, Bishara N, Ackerly T, et al. Enhancement of radiation effects by gold nanoparticles for superficial radiation therapy. Nanomedicine 2009;5: 136-42.
15. Kojima C, Hirano Y, Yuba E, Harada A, Kono K. Preparation and characterization of complexes of liposomes with gold nanoparticles. Colloids Surf B Biointerfaces 2008;66: 246-52.
16. Berbeco RI, Ngwa W, Makrigiorgos GM. Localized dose enhancement to tumor blood vessel endothelial cells via megavoltage X-rays and targeted gold nanoparticles: new potential for external beam radiotherapy. Int J Radiat Oncol Biol Phys 2011;81: 270-6.
17. Retif P, Pinel S, Toussaint M, et al. Nanoparticles for radiation therapy enhancement: the key parameters. Theranostics 2015;5: 1030-44.
18. Chung US, Kim JH, Kim B, Kim E, Jang WD, Koh WG. Dendrimer porphyrin-coated gold nanoshells for the synergistic combination of photodynamic and photothermal therapy. Chem Commun (Camb) 2016;52: 1258-61.
19. Hall EJ, Giaccia AJ. Oxygen effect and reoxygenation. In: Hall EJ, Giaccia AJ, editors. Radiobiology for the radiologist. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2012. p. 86-103.
20. Bindra RS, Crosby ME, Glazer PM. Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev 2007;26: 249-60.
21. Park HJ, Griffin RJ, Hui S, Levitt SH, Song CW. Radiation-induced vascular damage in tumors: implications of vascular damage in ablative hypofractionated radiotherapy (SBRT and SRS). Radiat Res 2012;177: 311-27.
22. Butterworth KT, Coulter JA, Jain S, et al. Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy. Nanotechnology 2010;21: 295101.
23. Butterworth KT. Radiosensitization by gold nanoparticles: effective at megavoltage energies and potential role of oxidative stress. Transl Cancer Res 2013;2: 269-79.
24. Misawa M, Takahashi J. Generation of reactive oxygen species induced by gold nanoparticles under x-ray and UV Irradiations. Nanomedicine 2011;7: 604-14.
25. Ngwa W, Kumar R, Sridhar S, et al. Targeted radiotherapy with gold nanoparticles: current status and future perspectives. Nanomedicine (Lond) 2014;9: 1063-82.
26. Hagtvet E, Roe K, Olsen DR. Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts. Radiat Oncol 2011;6: 135.